• 2019 Esc/Eas Guidelines For The Management Of Dyslipidaemias: Lipid Modification To Reduce Cardiovascular Risk 

      Mach, Francois; Baigent, Colin; Catapano, Alberico L.; Koskina, Konstantinos C.; Casula, Manuela; Badimon, Lina; Chapman, M. John; De Backer, Guy G.; Delgado, Victoria; Ference, Brian A.; Graham, Ian M.; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R.; Riccardi, Gabriele; Richter, Dimitrios J.; Sabatine, Marc S.; Taskinen, Marja-Riitta; Tokgozoglu, Lale; Wiklund, Olov; Windecker, Stephan; Aboyans, Victor; Baigent, Colin; Collet, Jean-Philippe; Dean, Veronica; Delgado, Victoria; Fitzsimons, Donna; Gale, Chris P.; Grobbee, Diederick; Halvorsen, Sigrun; Hindricks, Gerhard; Iung, Bernard; Juni, Peter; Katus, Hugo A.; Leclercq, Christophe; Lettino, Maddalena; Lewis, Basil S.; Merkely, Bela; Mueller, Christian; Petersen, Steffen; Petronio, Anna Sonia; Roffi, Marco; Shlyakhto, Evgeny; Simpson, Iain A.; Sousa-Uva, Miguel; Touyz, Rhian M.; Nibouche, Djamaleddine; Zelveian, Parounak H.; Siostrzonek, Peter; Najafov, Ruslan; Van de Bornear, Philippe; Pojskic, Belma; Postadzhiyan, Arman; Kypris, Lambros; Spinar, Jindrich; Larsen, Mogens Lytken; Eldin, Hesham Salah; Viigimaa, Margus; Strandberg, Timo E.; Ferrieres, Jean; Agladze, Rusudan; Laufs, Ulrich; Rallidis, Loukianos; Bajnok, Laszlo; Gudjonsson, Thorbjorn; Maher, Vincent; Henkin, Yaakov; Gulizia, Michele Massimo; Mussagaliyeva, Aisulu; Bajraktari, Gani; Kerimkulova, Alina; Latkovskis, Gustavs; Hamoui, Omar; Slapikas, Rimvydas; Visser, Laurent; Dingli, Philip; Ivanov, Victoria; Boskovic, Aneta; Nazzi, Mbarek; Visseren, Frank; Mitevska, Irena; Retterstol, Kjetil; Jankowski, Piotr; Fontes-Carvalho, Ricardo; Gaita, Dan; Ezhov, Marat; Foscoli, Marina; Giga, Vojislav; Pella, Daniel; Fras, Zlatko; de Isla, Leopoldo Perez; Hagstrom, Emil; Lehmann, Roger; Abid, Leila; Ozdogan, Oner; Mitchenko, Olena; Patel, Riyaz S.; Members, Task Force; CPG, ESC Comm Practice Guidelines; Societies, ESC Natl Cardiac (2019)
    • The Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (Spparmα) Paradigm: Conceptual Framework And Therapeutic Potential 

      Fruchart, Jean-Charles; Santos, Raul D.; Aguilar-Salinas, Carlos; Aikawa, Masanori; Al Rasadi, Khalid; Amarenco, Pierre; Barter, Philip J.; Ceska, Richard; Corsini, Alberto; Després, Jean-Pierre; Duriez, Patrick; Eckel, Robert H.; Ezhov, Marat V.; Farnier, Michel; Ginsberg, Henry N.; Hermans, Michel P.; Ishibashi, Shun; Karpe, Fredrik; Kodama, Tatsuhiko; Koenig, Wolfgang; Krempf, Michel; Lim, Soo; Lorenzatti, Alberto J.; McPherson, Ruth; Nuñez-Cortes, Jesus Millan; Nordestgaard, Børge G.; Ogawa, Hisao; Packard, Chris J.; Plutzky, Jorge; Ponte-Negretti, Carlos I.; Pradhan, Aruna; Ray, Kausik K.; Reiner, Željko; Ridker, Paul M.; Ruscica, Massimiliano; Sadikot, Shaukat; Shimano, Hitoshi; Sritara, Piyamitr; Stock, Jane K.; Su, Ta-Chen; Susekov, Andrey V.; Tartar, André; Taskinen, Marja-Riitta; Tenenbaum, Alexander; Tokgözoğlu, Lale S.; Tomlinson, Brian; Tybjærg-Hansen, Anne; Valensi, Paul; Vrablík, Michal; Wahli, Walter; Watts, Gerald F.; Yamashita, Shizuya; Yokote, Koutaro; Zambon, Alberto; Libby, Peter (2019)
      In the era of precision medicine, treatments that target specific modifiable characteristics of high-risk patients have the potential to lower further the residual risk of atherosclerotic cardiovascular events. Correction ...